Executive Search Success Story: Recruiting a CEO & President for a High-Growth Medical Device Company

How JRG Partners ran a confidential, multi-role executive search for a high-growth medical device company entering a critical expansion phase. The strategy equipped the enterprise with the critical C-suite, commercial, and operational leadership required to balance technology innovation, regulatory navigation, and aggressive commercialization while scaling for global demand.

The Challenge

A high-growth medical device company was entering a critical phase of expansion. It needed top executive leadership able to balance innovation, commercialization, and operational excellence while scaling for global demand. Board directors and stakeholders identified several critical structural and market pressures:

• Scaling complex manufacturing and supply chain operations to support increasing global demand
• Preparing for upcoming new product launches and intensive market expansion initiatives
• Navigating complex FDA and international regulatory environments under strict oversight
• Strengthening strategic relationships with institutional investors, healthcare providers, and partners
• Developing robust, long-term succession plans for critical senior leadership roles
• Identifying elite executives capable of balancing technical innovation, commercialization, and operational excellence

The mandate included confidential recruitment across a Chief Executive Officer, President, Chief Commercial Officer, Chief Operating Officer, VP Sales, VP Marketing, VP Regulatory Affairs, and VP Clinical Affairs. Successfully executing this top-tier, multi-role recruitment drive required an executive search partner with deep medical device C-suite search expertise. For organizations evaluating how advanced medical technologies scale complex corporate architectures under strict regulation, a parallel analysis can be reviewed in Drug_Device_C_Whitelabeled.docx.

Why They Chose JRG Partners

Deep Medical Device C-Suite Specialization

Our dedicated practices span medical device top executive leadership, commercial strategy, and global operations. We maintain deep functional fluency in the operational metrics, investor relations, and clinical regulatory hurdles unique to high-growth healthcare technology enterprises.

Real Access to Passive Talent

Many of the most impactful C-suite and executive leaders are fully integrated into high-performing operations and are not actively browsing traditional channels. JRG Partners bypassed conventional recruitment platforms entirely, utilizing long-standing sector relationships and proprietary market intelligence to engage high-achieving passive leaders invisible through standard sourcing methods.

Confidential Search Execution

With an enterprise-level executive transition and critical market expansions at stake, absolute discretion was mandatory. JRG Partners deployed a secure, confidential vetting and outreach protocol that successfully protected client continuity, insulated strategic market positioning, and maintained total candidate and investor trust.

Broad Reach

Sourcing elite executive, commercial, and operational leadership capable of leading a global medical brand required an outreach strategy unconstrained by geography. The search targeted proven leaders from premier medical device, diagnostic, and surgical technology organizations across major international technology hubs.

Our Corporate Search Strategy

Phase 1 — Leadership Assessment

We worked directly with the board and executive team to map organizational gaps, identify succession risks, clarify growth objectives, and define the exact leadership competencies the business would need as it scaled globally. Profiles were built dynamically against the company’s long-term strategy rather than legacy job descriptions.

Phase 2 — Market Mapping

JRG Partners executed an exhaustive market-mapping initiative across the medical technology landscape. Our map targeted key talent pools within medical device manufacturers, diagnostic device companies, surgical technology organizations, cardiovascular and orthopedic device firms, healthcare technology providers, and private equity-backed healthcare companies.

Phase 3 — Engagement

Using a research-driven, highly discreet outreach framework, our consultants directly contacted and evaluated corporate, commercial, and technical leaders with verified records of driving medical device growth. Only candidates demonstrating clear operational acumen and measurable impact advanced.

Phase 4 — Assessment & Selection

Each finalist candidate went through an extensive evaluation process looking far beyond basic credentials. Our consultants conversion-tested strategic and functional capabilities, international commercial agility, regulatory navigation knowledge, leadership and team-building philosophies, cultural alignment, and long-term retention potential.

Key Outcomes

• 350+ senior medical device, diagnostic, and surgical technology executive profiles systematically mapped and evaluated across domestic and international innovation hubs.
• Successfully executed a comprehensive, confidential multi-role leadership mandate, placing key executives across all targeted divisions.
• Recruited and integrated high-impact executives across CEO, President, Chief Commercial Officer, COO, VP Sales, VP Marketing, VP Regulatory Affairs, and VP Clinical Affairs roles.
• Bypassed conventional channels to secure high-performing passive talent from leading global telemetry networks, surgical innovators, and device manufacturing operations.
• Aligned organizational infrastructure with future-proof competency profiles tied dynamically to global expansion metrics, multi-market regulatory compliance, and cross-functional operational efficiency.
• Protected sensitive commercial product launches, corporate capitalization plans, and clinical testing metrics through strict search confidentiality during a critical growth phase.
• Equipped the Board of Directors with a high-performance management framework primed to manage global operations, maintain strict compliance, and drive scalable market success.